Showing 20 of 82 recruiting trials for “aggressive-systemic-mastocytosis”
Platform Clinical Study for Conquering Scleroderma
Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung Disease
👨⚕️ Camille DASTE, MD, Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)📍 1 site📅 Started Apr 2024View details ↗
Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
👨⚕️ Afshin GANGI, MD, PhD, Hôpitaux Universitaires de Strasbourg📍 13 sites📅 Started Mar 2024View details ↗
RecruitingNCT06268457 ↗
Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis
RecruitingNCT06224283 ↗
Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
👨⚕️ Zsuzsanna H McMahan, MD, MHS (M-PI), The University of Texas Health Science Center, Houston📍 1 site📅 Started Feb 2024View details ↗
Open Label Extension Study of Brentuximab Vedotin in Early dcSSc
👨⚕️ Janet E Pope, PhD, University of Western Ontario, Division of Rheumatology, St. Joseph's Health Care, London, Ontario, Canada📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06051773 ↗
Evaluation of Muscle Involvement in Systemic Sclerosis
Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate
👨⚕️ Dr MD. Fahad Hossain, MBBS, MD, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh📍 1 site📅 Started Jan 2024View details ↗
RY_SW01 Cell Injection Therapy in Systemic Sclerosis
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Enrolling by InvitationNCT06847750 ↗
Elastography Ultrasound in Localized Scleroderma (Morphea) Study
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
👨⚕️ Luc Mouthon, MD-PhD, Assistance Publique - Hôpitaux de Paris📍 46 sites📅 Started Feb 2023View details ↗
RecruitingNCT05482607 ↗
Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
RecruitingNCT05505617 ↗
Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis
RecruitingNCT05532865 ↗
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis
👨⚕️ Chadwick Prodromos, MD, The Foundation for Orthopaedics and Regenerative Medicine📍 2 sites📅 Started Jul 2022View details ↗
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
👨⚕️ Marie-Elise TRUCHETET, Prof, University Hospital, Bordeaux📍 10 sites📅 Started Jun 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →